Navigation Links
Liberty Institute: Government "Accommodation" Still Requires Employers To Facilitate Coverage Of Abortifacient Drugs
Date:8/22/2014

WASHINGTON, Aug. 22, 2014 /PRNewswire-USNewswire/ -- Today, the Obama Administration issued new regulations under Obamacare that modify the religious "accommodation" but still require religious organizations to facilitate insurance coverage for drugs that have an abortifacient effect, including Plan B (the "morning after pill") and Ella (the "week after pill"). The Obama Administration also announced that it is investigating expanding the "accommodation" to religious, closely held, for-profit corporations.

The regulations issued today keep the same "accommodation" in place but provide an alternative means of accepting the "accommodation." Instead of submitting the previously required form, religious organizations may now elect instead to notify the government in writing of their objection to providing the abortifacient coverage using words of the organization's own choice.

"Eliminating the requirement of using the government's form does not eliminate moral liability for facilitating coverage of these abortifacient drugs," said Jeff Mateer, general counsel of Liberty Institute. "These new regulations are a mere hand wave to Americans who, inspired by their deep religious commitment, oppose providing drugs that may kill an unborn baby."

Last month, in the wake of the Hobby Lobby and Wheaton College Supreme Court decisions prohibiting the Obama Administration from forcing religious employers to facilitate or provide coverage for these abortifacient drugs, the administration announced that it would issue new regulations that would protect religious employers' religious freedom. Those new regulations, issued today, keep the same fundamental system in place to which so many employers have objected.

Under the "religious accommodation," religious organizations could submit a form that would trigger a requirement that the organization's insurance provider cover the objectionable drugs. Many faith-based organizations objected that forcing their insurance providers to cover drugs like Plan B and Ella was no less morally objectionable than including the drugs directly in the organizations' health insurance policies.

Liberty Institute is a nonprofit legal group dedicated to defending and restoring religious liberty across America — in our schools, for our churches, in the military and throughout the public arena. Liberty's vision is to reestablish religious liberty in accordance with the principles of our nation's Founders. For information, visit www.LibertyInstitute.org.

Logo - http://photos.prnewswire.com/prnh/20120523/DC12743LOGO-b


'/>"/>
SOURCE Liberty Institute
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Liberty Design Secures GSA Award, to Supply Federal Agencies
2. New England Laser Options Adds On Professional Hair Removal with the Astanza Liberty IPL System
3. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
4. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
5. The American Council for Patient Liberty on medical marijuana vending machines
6. Liberty Dialysis Celebrates Milestone 1,000th Patient in Peritoneal Dialysis Program
7. Incentivated Helps Scottish Government Service Consumers by SMS
8. Government Affairs & Public Policy Groups Playing Critical Role in Patient Engagement, Reports Best Practices, LLC
9. State Governments May Spend $55 Billion on Hepatitis C Medications
10. Government Testing Error Forces Delay in Planned Launch of New MSA Air Masks
11. AMRI Awarded Development and Manufacture Contract from the UK Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 AcelRx ... focused on the development and commercialization of innovative ... announced that it will release fourth quarter and ... March 2nd, 2017. AcelRx management will host an ... (1:30 p.m. Pacific Time) on March 2 nd ...
(Date:2/23/2017)... COTTAGE, New York , February 23, 2017 /PRNewswire/ ... health implications arising from increasing caseload for varicose veins ... recorded across the globe are prompting the adoption of ... latest study on global endovenous laser therapy ... attention towards aftereffects of lifestyle choices and consequences of ...
(Date:2/23/2017)... Research and Markets has announced the addition ... Forecast to 2025" report to their offering. ... The Global Endoscopy Market is ... next decade to reach approximately $47.6 billion by 2025. ... all the given segments on global as well as regional levels ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
(Date:2/23/2017)... Lawn, NJ (PRWEB) , ... February 23, 2017 ... ... specializing in thought leadership , media relations, content marketing, social media management, ... With several clients already in the state and in nearby New Hampshire, Massachusetts ...
(Date:2/23/2017)... Angeles, California (PRWEB) , ... February 23, 2017 ... ... Global Sports Development will host a diverse symposium on “Doping in ... of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will be ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... interactive publication where generations converge and explore the world from different perspectives. By ... Magazine enables readers to gain understanding, increase empathy, and find greater happiness. ...
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , a ... franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation for ... mainstream. Current Meditation will be the first meditation concept in the U.S. offering ...
Breaking Medicine News(10 mins):